Cellbyte
New accelerator entry · 2022-01-25 · the record
In their words
Cellbyte's AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“. The three co-founders have known and worked with each other for many years: Daniel brings 5+ years of industry experience from his previous job at leading global Life Sciences consultancy Simon-Kucher. Felix has sold $3m+ ACV deals to customers like H&M for his previous YC startup. Samuel holds an MSc in Information Systems from TUM, and has built enterprise AI applications from scratch as ML Engineer at Celonis.
What the record says
- One of 141 companies held here in Healthcare › Healthcare IT.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Cellbyte
- Source Check — verify what Cellbyte states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Cellbyte for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist CellbyteYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Cellbyte: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.